Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Targeted Oncology|September 1, 2017
The Current Landscape of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer: Emerging Treatment Paradigms and Future DirectionsAngel Qin, Shirish GadgeelLung Cancer (Auckland, N.Z.)|June 27, 2019
Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancerFrank Weinberg, Shirish GadgeelLung Cancer (Auckland, N.Z.)|February 18, 2017
New options in the management of intractable ALK(+) metastatic non-small-cell lung cancerAmy M Weise, Shirish GadgeelAnnals of Translational Medicine|February 7, 2017
MET/HGF pathway activation as a paradigm of resistance to targeted therapiesBrian Ko, Tianfang He, Shirish Gadgeel, et al.Breast Cancer Research and Treatment|January 20, 2009
An educational video to increase clinical trials enrollment among breast cancer patientsWei Du, Darlene Mood, Shirish Gadgeel, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
An educational video to increase clinical trials enrollment among lung cancer patientsWei Du, Darlene Mood, Shirish Gadgeel, et al.Clinical Lung Cancer|December 22, 2023
Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLCElaine M Jennings, D Ross Camidge, Shirish Gadgeel, et al.Expert Review of Respiratory Medicine|December 10, 2019
The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancerMariam Alexander, Brian Ko, Remy Lambert, et al.Molecular Cancer Therapeutics|February 22, 2023
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer CellsJitender Monga, Frederick Valeriote, Clara Hwang, et al.Targeted Oncology|March 21, 2022
Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung CancerFawzi Abu Rous, Radhika Gutta, Pin Li, et al.Pageof 11